Fred A. Middleton
Chairman of the Board
"Fred Middleton has over 30 years of experience in the biotechnology and biomedical industries in both corporate operating management and as an institutional venture capital investor. He is currently Managing Director of Sanderling Ventures where he has, over time, served as an investor, management team member and director in over 25 new biomedical ventures built in the firm’s investment portfolios since 1988. Prior to his career in venture capital, Mr. Middleton served as the founding Chief Financial Officer and Vice President of Corporate Development at Genentech. Mr. Middleton earned his B.S. in chemistry from the Massachusetts Institute of Technology and an M.B.A with distinction from the Harvard Business School. He serves as a member of the MIT Corporation (board of trustees). "